BMO Capital Maintains Outperform on Exelon, Raises Price Target to $52

Benzinga Newsdesk www.benzinga.com Positive 89.9%

Neg 0% Neu 0% Pos 89.9%

BMO Capital analyst James Thalacker maintains Exelon (NASDAQ:EXC) with a Outperform and raises the price target from $51 to $52.